---
title: "Eli Lilly (United States): research papers"
description: "From 2017 to 2026 (so far), authors at Eli Lilly (United States) took part in 24 papers in the tracked journals, most of them in statistics (11), health economics and policy (11) and marketing (2). 1 of them were published in 2025, against 0 in 2017."
url: https://scholar4ai.com/companies/eli-lilly-united-states
markdown_url: https://scholar4ai.com/companies/eli-lilly-united-states.md
license: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
share_text: "From 2017 to 2026 (so far), authors at Eli Lilly (United States) took part in 24 papers in the tracked journals, most of them in statistics (11), health economics and policy (11) and marketing (2). 1 of them were… (as of 2026-10-31)"
data_url: https://scholar4ai.com/data/rankings.json
updated: 2026-10-31T19:11:11+09:00
window: 2026-10-02 to 2026-10-31
source: OpenAlex (CC0)
---

# Eli Lilly (United States)

Papers in the tracked journals with an author at Eli Lilly (United States): per year and category, where they are published, the institutions its researchers write with, and its most-cited papers. A paper counts as corporate when at least one of its authors is affiliated with an institution that OpenAlex classifies as a company; it counts once for each company among its authors' affiliations. Universities are the institutions OpenAlex classifies as education.

Back to the ranking: https://scholar4ai.com/rankings/companies.md

## Key findings

- From 2017 to 2026 (so far), authors at Eli Lilly (United States) took part in 24 papers in the tracked journals, most of them in statistics (11), health economics and policy (11) and marketing (2).
- 1 of them were published in 2025, against 0 in 2017.
- Since 2023, the institutions with the most of these papers were Bristol-Myers Squibb (United Kingdom) (1), Bristol-Myers Squibb (United States) (1) and Florida State University (1).
- The journals publishing most of them were Lifetime Data Analysis (3), Statistics & Probability Letters (1) and Journal of Statistical Planning and Inference (1).
- The most-cited of them is “Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines” (The European Journal of Health Economics, 2020), with 310 citations.
- Since 2023, papers in the tracked journals cited 11 of its papers 74 times; 97% of those links came from papers with a university author and 0% from its own papers.
- Its own papers since 2023 cite archived papers 9 times, 33% of them papers with a company author.

## Papers per year

*Papers per publication year and category*

| Category | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (so far) |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| [Statistics](https://scholar4ai.com/categories/statistics.md) | 0 | 2 | 0 | 0 | 3 | 0 | 0 | 3 | 1 | 2 |
| [Health Economics and Policy](https://scholar4ai.com/categories/health-economics-and-policy.md) | 0 | 2 | 3 | 3 | 0 | 2 | 0 | 0 | 0 | 1 |
| [Marketing](https://scholar4ai.com/categories/marketing.md) | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| All categories | 0 | 4 | 4 | 4 | 3 | 2 | 0 | 3 | 1 | 3 |

## Where the papers come from

*Journals with the most papers, since 2023*

| # | Journal | Papers |
|---:|---|---:|
| 1 | [Lifetime Data Analysis](https://scholar4ai.com/journals/lifetime-data-analysis.md) | 3 |
| 2 | [Statistics & Probability Letters](https://scholar4ai.com/journals/statistics-probability-letters.md) | 1 |
| 3 | [Journal of Statistical Planning and Inference](https://scholar4ai.com/journals/journal-of-statistical-planning-and-inference.md) | 1 |
| 4 | [Applied Health Economics and Health Policy](https://scholar4ai.com/journals/applied-health-economics-and-health-policy.md) | 1 |
| 5 | [Journal of Statistical Theory and Practice](https://scholar4ai.com/journals/journal-of-statistical-theory-and-practice.md) | 1 |

*Institutions with the most papers, since 2023*

| # | Institution | Papers |
|---:|---|---:|
| 1 | Bristol-Myers Squibb (United Kingdom) | 1 |
| 2 | Bristol-Myers Squibb (United States) | 1 |
| 3 | Florida State University | 1 |
| 4 | Hospital Universitario 12 De Octubre | 1 |
| 5 | Indiana University Indianapolis | 1 |
| 6 | Indiana University School of Medicine | 1 |
| 7 | Information Management Services | 1 |
| 8 | London School of Hygiene & Tropical Medicine | 1 |
| 9 | National Cancer Institute | 1 |

*Countries with the most papers, since 2023*

| # | Country | Papers |
|---:|---|---:|
| 1 | United States | 7 |
| 2 | United Kingdom | 3 |
| 3 | Australia | 1 |
| 4 | Spain | 1 |
| 5 | Netherlands | 1 |

*Keywords with the most papers, since 2023*

| # | Keyword | Papers |
|---:|---|---:|
| 1 | consistency | 2 |
| 2 | B-splines | 1 |
| 3 | Bayesian estimation | 1 |
| 4 | Bayesian linear regression | 1 |
| 5 | Gibbs sampling | 1 |
| 6 | Harris recurrence | 1 |
| 7 | alcohol consumption | 1 |
| 8 | asymptotic normality | 1 |
| 9 | behavioral risk factors | 1 |
| 10 | breast cancer clinical trials | 1 |

## Most-cited papers

*Most-cited papers since 2017*

| # | Citations | Per month | Title | Journal | Published | Authors |
|---:|---:|---:|---|---|---|---|
| 1 | 310 | 4.0 | [Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines](https://doi.org/10.1007/s10198-020-01195-8) | [The European Journal of Health Economics](https://scholar4ai.com/journals/the-european-journal-of-health-economics.md) | 2020-06-08 | Matthew Kennedy-Martin, Bernhard Slaap, Michael J. Herdman et al. |
| 2 | 58 | 0.7 | [Beauty in the eyes of its beholders: Effects of design novelty on consumer preference](https://doi.org/10.1016/j.jretconser.2019.101969) | [Journal of Retailing and Consumer Services](https://scholar4ai.com/journals/journal-of-retailing-and-consumer-services.md) | 2019-10-18 | Fu Liu, Z. A. Zhu, Haipeng Allan Chen et al. |
| 3 | 30 | 0.4 | [Modeling Heterogeneity in Patients’ Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches](https://doi.org/10.1007/s40273-020-00894-7) | [PharmacoEconomics](https://scholar4ai.com/journals/pharmacoeconomics.md) | 2020-03-04 | Marco Boeri, Daniel Saure, Alexander Schacht et al. |
| 4 | 24 | 0.3 | [Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis](https://doi.org/10.1007/s41669-019-0152-1) | [PharmacoEconomics - Open](https://scholar4ai.com/journals/pharmacoeconomics-open.md) | 2019-06-08 | Natalie N. Boytsov, Xiang Zhang, Kristin A. Evans et al. |
| 5 | 18 | 0.2 | [Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy](https://doi.org/10.1007/s10198-020-01229-1) | [The European Journal of Health Economics](https://scholar4ai.com/journals/the-european-journal-of-health-economics.md) | 2020-10-06 | Johannes Pöhlmann, Kirsi Norrbacka, K. Boye et al. |
| 6 | 17 | 0.2 | [The Upside of Down: Presenting a Price in a Low or High Location Influences How Consumers Evaluate It](https://doi.org/10.1016/j.jretai.2020.02.003) | [Journal of Retailing](https://scholar4ai.com/journals/journal-of-retailing.md) | 2020-03-30 | Michael J. Barone, Keith S. Coulter, Xingbo Li |
| 7 | 13 | 0.1 | [A joint design for functional data with application to scheduling ultrasound scans](https://doi.org/10.1016/j.csda.2018.01.009) | [Computational Statistics & Data Analysis](https://scholar4ai.com/journals/computational-statistics-data-analysis.md) | 2018-01-31 | So Young Park, Luo Xiao, Jayson D. Wilbur et al. |
| 8 | 10 | 0.1 | [A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA](https://doi.org/10.1007/s40273-019-00829-x) | [PharmacoEconomics](https://scholar4ai.com/journals/pharmacoeconomics.md) | 2019-08-27 | Elizabeth Wehler, Natalie N. Boytsov, Claudia Nicolay et al. |
| 9 | 8 | 0.1 | [Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation](https://doi.org/10.1007/s40258-018-0379-5) | [Applied Health Economics and Health Policy](https://scholar4ai.com/journals/applied-health-economics-and-health-policy.md) | 2018-03-10 | William J. Valentine, Kate Van Brunt, Kristina Secnik Boye et al. |
| 10 | 7 | 0.1 | [Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data](https://doi.org/10.1186/s13561-018-0199-1) | [Health Economics Review](https://scholar4ai.com/journals/health-economics-review.md) | 2018-08-27 | Johannes Clouth, Astra M. Liepa, Guido Moeser et al. |

## Who cites its research

*Institutions whose papers cite it most, since 2023*

| # | Institution | Kind | Country | Links |
|---:|---|---|---|---:|
| 1 | EuroQol Research Foundation | Nonprofit | Netherlands | 10 |
| 2 | Erasmus University Rotterdam | University | Netherlands | 10 |
| 3 | Corvinus University of Budapest | University | Hungary | 7 |
| 4 | SGH Warsaw School of Economics | University | Poland | 6 |
| 5 | University of Sheffield | University | United Kingdom | 6 |
| 6 | Semmelweis University | University | Hungary | 5 |
| 7 | The University of Melbourne | University | Australia | 5 |
| 8 | [National University of Singapore](https://scholar4ai.com/institutions/national-university-of-singapore.md) | University | Singapore | 5 |
| 9 | The University of Sydney | University | Australia | 4 |
| 10 | Shandong University | University | China | 4 |

## What its papers cite

*Institutions its papers cite most, since 2023*

| # | Institution | Kind | Country | Links |
|---:|---|---|---|---:|
| 1 | University of Sheffield | University | United Kingdom | 2 |
| 2 | Worcester Polytechnic Institute | University | United States | 1 |
| 3 | Isfahan University of Medical Sciences | University | Iran | 1 |
| 4 | Biogen (United States) | Company | United States | 1 |
| 5 | Royal Marsden NHS Foundation Trust | Healthcare | United Kingdom | 1 |
| 6 | Memorial Sloan Kettering Cancer Center | Healthcare | United States | 1 |
| 7 | University of Wisconsin–Madison | University | United States | 1 |
| 8 | Zhongnan University of Economics and Law | University | China | 1 |
| 9 | University of California, Los Angeles | University | United States | 1 |
| 10 | [Chinese Academy of Sciences](https://scholar4ai.com/institutions/chinese-academy-of-sciences.md) | Government | China | 1 |

More: https://scholar4ai.com/corporate-citations.md · https://scholar4ai.com/industry-university.md

## Cite this page

Scholar4AI. (2026). Eli Lilly (United States). Journal Research Rankings. Retrieved October 31, 2026, from https://scholar4ai.com/companies/eli-lilly-united-states

```bibtex
@misc{scholar4ai-companies-eli-lilly-united-states,
  author = {{Scholar4AI}},
  title = {Eli Lilly (United States)},
  year = {2026},
  howpublished = {\url{https://scholar4ai.com/companies/eli-lilly-united-states}},
  urldate = {2026-10-31},
  note = {Journal Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0}
}
```

License: CC BY-NC 4.0 (https://creativecommons.org/licenses/by-nc/4.0/).